Phase-2 trial of Bharat Biotech's Covid-19 vaccine set to begin at PGI Rohtak

Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine. Speaking to ANI, Dr OP Kalra, vice-chancellor, PGI Rohtak said, "We got permission from Bharat Biotech to start a phase-2 human clinical trial of their vaccine. We've 300 volunteers, aged between 12 years and 65- years, out of which screening of 15 has been completed."